Let's not forget the fact that the EFFda disallowed any more EINDs with the ABSURD excuse that it would help CYDY finish their trial faster. Really? I'd argue that all these other trials that are well funded are doing a much better job at slowing CYDY's trial progress much more than disallowing leronlimab.

The REAL reason for the EFFda stopping EIND application of leronlimab is obvious.